452327AK5
Illumina, Inc.
Could not find a ticker for this position, may be a filing error
A maker of DNA sequencing and genetic analysis instruments, Illumina is one of the world's largest genomics technology companies, serving researchers and clinicians in noninvasive prenatal testing and cancer detection. Founded in 1998 in San Diego by a venture capitalist and a Tufts chemist, its name comes from the Latin word for 'light,' a nod to its fluorescence-based detection—and despite how it sounds, it has nothing to do with the Illuminati. Sequencing machines like the MiSeq decode genomes.
CONVERTIBLEUnderlying: ILMNCUSIP: 452327AK5HealthcareUS1 derivative reporter
0% convertible bond due 08/15/2023
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
